Cargando…
Repurposing of rabeprazole as an anti-Trypanosoma cruzi drug that targets cellular triosephosphate isomerase
Trypanosoma cruzi is the causative agent of American trypanosomiasis, which mainly affects populations in Latin America. Benznidazole is used to control the disease, with severe effects in patients receiving this chemotherapy. Previous studies have demonstrated the inhibition of triosephosphate isom...
Autores principales: | García-Torres, Itzhel, De la Mora-De la Mora, Ignacio, López-Velázquez, Gabriel, Cabrera, Nallely, Flores-López, Luis Antonio, Becker, Ingeborg, Herrera-López, Juliana, Hernández, Roberto, Pérez-Montfort, Ruy, Enríquez-Flores, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351538/ https://www.ncbi.nlm.nih.gov/pubmed/37401012 http://dx.doi.org/10.1080/14756366.2023.2231169 |
Ejemplares similares
-
Deamidated Human Triosephosphate Isomerase is a Promising Druggable Target
por: Enríquez-Flores, Sergio, et al.
Publicado: (2020) -
Perturbation of the Dimer Interface of Triosephosphate Isomerase and its Effect on Trypanosoma cruzi
por: Olivares-Illana, Vanesa, et al.
Publicado: (2007) -
Human Triosephosphate Isomerase Is a Potential Target in Cancer Due to Commonly Occurring Post-Translational Modifications
por: Enríquez-Flores, Sergio, et al.
Publicado: (2023) -
Naturally occurring deamidated triosephosphate isomerase is a promising target for cell-selective therapy in cancer
por: Enríquez-Flores, Sergio, et al.
Publicado: (2022) -
Structural Effects of Protein Aging: Terminal Marking by Deamidation in Human Triosephosphate Isomerase
por: de la Mora-de la Mora, Ignacio, et al.
Publicado: (2015)